Insulet Corporation (PODD)

Nasdaq · Healthcare · Medical Devices
$133.17-2.96%As of 2026-11-22 · USD
Last session low $132.43Last session high $140.47
52-week low $126.4052-week high $342.13
Market cap
$9.24B
Sector
Healthcare
P/E (TTM)
21.8x

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in USD.

IndicatorValueReading
RSI (14)38.8In the neutral range (30 to 70)
MACD (12, 26, 9)-0.98Below its signal line (1.19); histogram -2.17
Bollinger %B (20, 2)-13%Below the lower band (136.35 to 161.68)
SMA 20149.01Price is 10.6% below
SMA 50142.34Price is 6.4% below
SMA 200169.94Price is 21.6% below
ATR (20)4.65% of priceAverage true range per day
52-week position3%In the lower part of the 126.40 to 342.13 range

About Insulet Corporation

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally.

Latest fiscal yearEnded 2025-12-31: revenue of $2.71B and an operating margin of 17.5%.

More in Medical Devices